TYPES OF BREAST CANCER
Learn the main types of breast cancer, how they are classified, and common treatment approaches—helping patients and caregivers better understand diagnosis and care options.
EXPLORE
Breast Cancer • Types • Diagnosis & Treatment
Understanding the different types of breast cancer can help patients and caregivers make informed decisions about diagnosis, treatment, and care.
Quick answer: Breast cancer includes several types—such as ductal, lobular, and inflammatory breast cancer—each with different characteristics, treatment approaches, and outcomes.
Breast cancer is not a single disease but a group of conditions that develop in different parts of the breast and behave in different ways.
Definition: Breast cancer types are classifications based on where the cancer begins (such as ducts or lobules), how it grows, and specific biological markers that influence treatment decisions.
The most common forms include ductal carcinoma, which begins in the milk ducts, and lobular carcinoma, which starts in the milk-producing glands. Other, less common types may behave more aggressively or require specialized care.
Did you know? Advances in screening and treatment have significantly improved early detection and survival rates for many types of breast cancer.
Understanding these classifications helps guide treatment options, which may include surgery, chemotherapy, radiation therapy, hormone therapy, and targeted therapies depending on the specific type and stage.
This page explores the major types of breast cancer, potential contributing factors, and the range of treatment approaches available today.
Growing to Give does not provide medical advice, diagnosis, or treatment. The information shared is for educational and community-support purposes only and is not a substitute for professional medical care. Always consult a qualified healthcare professional regarding any medical condition or treatment decisions.
Breast cancer develops when cells in the breast grow uncontrollably, forming a tumor that may invade nearby tissue or spread to other parts of the body. There is no single cause, but several factors can increase risk:
• Inherited gene changes (including well-known susceptibility genes) account for a portion of cases.
• A family history of breast or ovarian cancer can raise personal risk.
• Early menstruation (before ~12) or later menopause (after ~55).
• Long-term use of certain hormone therapies.
• Never having been pregnant, or first pregnancy after ~30.
• Limited physical activity and obesity, particularly after menopause.
• Excessive alcohol intake.
• Prior radiation exposure or contact with endocrine-disrupting chemicals.
• Diet high in saturated fats and low in fruits and vegetables.
• Risk increases with age, and women are more frequently affected than men.
Breast cancers are classified by where they begin and whether they remain localized or have spread.
A non-invasive cancer that starts in the milk ducts. It has not spread beyond the duct walls and is highly treatable when detected early.
The most common type begins in the ducts and invades surrounding breast tissue. Without treatment, it can spread to lymph nodes or distant organs.
Starts in the milk-producing lobules and spreads to nearby tissues. ILC can be harder to detect on mammogram and may require ultrasound or MRI.
Lacks estrogen, progesterone, and HER2 receptors. It tends to be more aggressive but can respond well to chemotherapy and, for some cases, immunotherapy-based approaches.
Characterized by extra HER2 signaling that promotes cell growth. Targeted therapies that block HER2 pathways have significantly improved outcomes for many people with this subtype.
Fueled by estrogen and/or progesterone. Endocrine therapy including receptor-blocking medicines or aromatase-inhibiting tablets—can slow or stop tumor growth by reducing hormone signals.
A rare, aggressive form that causes redness, swelling, and warmth due to blocked lymph vessels in the skin. Care generally involves a combination of systemic therapy, surgery, and radiation.
Cancer that has spread to other organs such as bone, lung, liver, or brain. While not curable, modern treatments can often control disease, relieve symptoms, and extend life.
Breast cancer is also classified by stage, which describes how far the cancer has spread in the body. Staging helps doctors determine the best treatment plan and understand prognosis.
Non-invasive cancers such as ductal carcinoma in situ (DCIS), where abnormal cells remain confined to the milk ducts.
Small tumors that have not spread far beyond the breast tissue.
Larger tumors or cancer that has spread to nearby lymph nodes.
More advanced local spread involving lymph nodes or chest wall tissues.
Also called metastatic breast cancer, where cancer has spread to distant organs such as bones, lungs, liver, or brain.
| Type | Where It Starts | Receptor Status | Common Treatments |
|---|---|---|---|
| Ductal Carcinoma In Situ (DCIS) | Milk ducts | Often hormone receptor positive | Surgery, radiation, endocrine therapy |
| Invasive Ductal Carcinoma (IDC) | Milk ducts | Varies | Surgery, chemotherapy, radiation |
| Invasive Lobular Carcinoma (ILC) | Lobules | Often hormone receptor positive | Surgery, endocrine therapy |
| Triple Negative | Various | ER-, PR-, HER2- | Chemotherapy, immunotherapy |
| HER2 Positive | Various | HER2+ | Targeted therapy + chemotherapy |
Treatment depends on type, stage, receptor status, genetics, and overall health. Plans are personalized and often combine several approaches.
• Lumpectomy: Removes the tumor with a margin of healthy tissue.
• Mastectomy: Removes part or all of the breast tissue, sometimes with lymph nodes..
• Reconstructive options may be discussed for physical and emotional recovery..
Targets remaining cancer cells after surgery to reduce recurrence risk; also used for symptom control in some advanced cases.
Uses medicines that target rapidly dividing cells. It may be given before surgery (neoadjuvant) to shrink tumors or after surgery (adjuvant) to lower recurrence risk.
For HR+ cancers, therapy reduces estrogen signaling or blocks estrogen receptors to slow or stop growth.
For appropriate subtypes, targeted medicines act on specific pathways—such as HER2 signaling or cell-cycle regulation—to inhibit cancer growth with greater precision.
In select cases—often certain triple-negative tumors—immune-checkpoint therapies may help the immune system recognize and attack cancer cells.
Healing from breast cancer is more than medical—it’s emotional, nutritional, and spiritual. Lifestyle changes such as balanced nutrition, gentle exercise, mindfulness, and joining support communities like Growing To Give’s Cancer Support Programs can help survivors rebuild strength and hope.
Early detection through mammograms, ultrasounds, and self-exams remains the most powerful defense. Awareness saves lives—and every shared story inspires courage.
Names/emails collected here are for nonprofit updates only and are not used for ads or linked to health status
The main types of breast cancer include ductal and lobular cancers. Some remain confined to the ducts or lobules, such as ductal carcinoma in situ (DCIS), while others become invasive and spread into nearby breast tissue. Subtypes such as hormone receptor-positive, HER2-positive, and triple-negative breast cancer are also classified based on receptor status.
Hormone receptor-positive breast cancer has estrogen receptors, progesterone receptors, or both. These cancers may respond to endocrine therapy that blocks hormone signals or lowers hormone production.
HER2-positive breast cancer has higher-than-normal levels of the HER2 protein, which can promote faster cancer cell growth. Many HER2-positive cancers are treated with targeted therapies designed to block this growth pathway.
Triple-negative breast cancer does not have estrogen receptors, progesterone receptors, or HER2 overexpression. It is often more aggressive than some other subtypes, but treatment options may include chemotherapy and, in some cases, immunotherapy.
Grade describes how abnormal the cancer cells look under a microscope and how quickly they may grow. Stage describes how far the cancer has spread in the breast, lymph nodes, or other areas of the body.
Breast cancer type is usually identified through imaging such as mammogram, ultrasound, or MRI, followed by a biopsy. Pathology reports often include the cancer type, receptor status, grade, and other important details used to guide treatment.
Depending on the type and stage, treatment may include surgery, radiation therapy, chemotherapy, endocrine therapy, targeted therapy, and immunotherapy. Treatment plans are personalized based on the diagnosis and the patient’s overall health.
Some people may be offered genetic counseling and testing, especially if they were diagnosed at a younger age, have a strong family history, or have certain tumor features. Genetic results can help guide treatment and family risk discussions.
Helpful questions include asking about your exact cancer type, stage, receptor status, treatment options, likely side effects, fertility or menopause concerns, clinical trials, and supportive care resources.
Support may be available through your oncology clinic, nurse navigator, hospital social worker, and local or online support groups. You can also explore our cancer support programs, Cancer Bites Podcast, and wellness resources such as aerobic exercise and forest bathing.
No. This page is for general educational and support purposes only. Always rely on your oncology team and other qualified healthcare professionals for diagnosis, treatment, and medical guidance.
.png)
.png)
.png)
.png)
Copyright Ⓡ 2026. All Rights Reserved. Growing To Give